Ebola images emerge from the cave.
Ebola virus causes a lethal hemorrhagic disease for which no therapy or vaccine is currently approved. Recently, the crystal structure of the Ebola virus glycoprotein in complex with a human neutralizing antibody was illuminated, providing a path from the shadows toward understanding cellular attachment, viral fusion, and immune evasion.
Diamond
Michael S
MS
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. diamond@borcim.wustl.edu
Fremont
Daved H
DH
D000818:Animals; D046129:Ebola Vaccines / Q000276:immunology; D029043:Ebolavirus / Q000737:chemistry* / Q000276:immunology / Q000502:physiology; D006023:Glycoproteins / Q000737:chemistry / Q000276:immunology; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology / Q000517:prevention & control / Q000821:virology*; D006801:Humans; D008958:Models, Molecular; D014759:Viral Envelope Proteins / Q000737:chemistry* / Q000276:immunology
D046129:Ebola Vaccines; D006023:Glycoproteins; D014759:Viral Envelope Proteins